Oruka Therapeutics, Current Valuation vs. Market Capitalization
| ORKA Stock | 20.75 0.25 1.22% |
For Oruka Therapeutics, profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Oruka Therapeutics, to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Oruka Therapeutics, utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Oruka Therapeutics,'s most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Oruka Therapeutics, over time as well as its relative position and ranking within its peers.
Oruka |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oruka Therapeutics,. If investors know Oruka will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oruka Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Oruka Therapeutics, is measured differently than its book value, which is the value of Oruka that is recorded on the company's balance sheet. Investors also form their own opinion of Oruka Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Oruka Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oruka Therapeutics,'s market value can be influenced by many factors that don't directly affect Oruka Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oruka Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Oruka Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oruka Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Oruka Therapeutics, Market Capitalization vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Oruka Therapeutics,'s current stock value. Our valuation model uses many indicators to compare Oruka Therapeutics, value to that of its competitors to determine the firm's financial worth. Oruka Therapeutics, is rated top company in current valuation category among its peers. It also is considered to be number one stock in market capitalization category among its peers creating about 0.99 of Market Capitalization per Current Valuation. The ratio of Current Valuation to Market Capitalization for Oruka Therapeutics, is roughly 1.01 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Oruka Therapeutics,'s earnings, one of the primary drivers of an investment's value.Oruka Current Valuation vs. Competition
Oruka Therapeutics, is rated top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 1.45 Billion. Oruka Therapeutics, totals roughly 899.11 Million in current valuation claiming about 62% of equities under Health Care industry.
Oruka Market Capitalization vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Oruka Therapeutics, |
| = | 899.11 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Oruka Therapeutics, |
| = | 888.26 M |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Oruka Market Capitalization vs Competition
Oruka Therapeutics, is considered to be number one stock in market capitalization category among its peers. Market capitalization of Health Care industry is now estimated at about 1.68 Billion. Oruka Therapeutics, totals roughly 888.26 Million in market capitalization claiming about 53% of equities under Health Care industry.
Oruka Therapeutics, Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Oruka Therapeutics,, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Oruka Therapeutics, will eventually generate negative long term returns. The profitability progress is the general direction of Oruka Therapeutics,'s change in net profit over the period of time. It can combine multiple indicators of Oruka Therapeutics,, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Oruka Therapeutics, is entity of United States. It is traded as Stock on NASDAQ exchange.
Oruka Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Oruka Therapeutics,. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Oruka Therapeutics, position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Oruka Therapeutics,'s important profitability drivers and their relationship over time.
| Current Valuation vs Shares Outstanding | ||
| Number Of Shares Shorted vs Market Capitalization | ||
| Current Valuation vs Target Price |
Use Oruka Therapeutics, in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Oruka Therapeutics, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oruka Therapeutics, will appreciate offsetting losses from the drop in the long position's value.Oruka Therapeutics, Pair Trading
Oruka Therapeutics, Pair Trading Analysis
The ability to find closely correlated positions to Oruka Therapeutics, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Oruka Therapeutics, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Oruka Therapeutics, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Oruka Therapeutics, to buy it.
The correlation of Oruka Therapeutics, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Oruka Therapeutics, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Oruka Therapeutics, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Oruka Therapeutics, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Oruka Therapeutics, position
In addition to having Oruka Therapeutics, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Aircraft Thematic Idea Now
Aircraft
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Aircraft theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aircraft Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center. For information on how to trade Oruka Stock refer to our How to Trade Oruka Stock guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
To fully project Oruka Therapeutics,'s future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Oruka Therapeutics, at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Oruka Therapeutics,'s income statement, its balance sheet, and the statement of cash flows.